UK at a glance
- Population
- 69.5 million 2025
- Life expectancy at birth
- 81.4 years, 2024
- People aged 65 and over
- 19.7 % of people, 2025
- Health spending per person
- 5,860 US$ per person, 2024
- Doctors
- 3.30 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
UK Disease Surveillance Systems Market Industry Trends and Forecast to 2034: Segmented by (Type, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$126.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $169.0 Mn | — | — |
| 2025 (base) | $179.3 Mn | +$10.3 Mn | — |
| 2026 (forecast) | $190.3 Mn | +$10.9 Mn | +6.1% |
| 2027 (forecast) | $201.9 Mn | +$11.6 Mn | +12.6% |
| 2028 (forecast) | $214.2 Mn | +$12.3 Mn | +19.4% |
| 2029 (forecast) | $227.3 Mn | +$13.1 Mn | +26.7% |
| 2030 (forecast) | $241.1 Mn | +$13.9 Mn | +34.5% |
| 2031 (forecast) | $255.8 Mn | +$14.7 Mn | +42.7% |
| 2032 (forecast) | $271.4 Mn | +$15.6 Mn | +51.4% |
| 2033 (forecast) | $288.0 Mn | +$16.6 Mn | +60.6% |
| 2034 (forecast) | $305.6 Mn | +$17.6 Mn | +70.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $179.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $305.6 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type and user (see all) |
| Key players | SAS Institute, Biobot Analytics, Ginkgo Bioworks, BlueDot, Esri (see all) |
| Regulator in the UK | MHRASource: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Disease surveillance systems collect and analyse data to spot outbreaks early and guide public health action.
Key segments of the disease Surveillance Systems market include type (Syndromic Surveillance, Lab-Based Surveillance and Genomic Surveillance) and user (Governments, WHO and NGOs and Hospitals).
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the disease Surveillance Systems market.
Digital tools for community health, local manufacturing and public-private partnerships give the disease Surveillance Systems market room to grow.
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the disease Surveillance Systems market.
The disease Surveillance Systems market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Software that works as a medical device is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) in the same way as other medical devices.[1] The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund.[2]
[1] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[2] National Institute for Health and Care Excellence. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the disease Surveillance Systems market. Government digital health programs in UK are speeding up adoption.
What doctors and scientists are doing in Disease Surveillance Systems right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
From our blog
UK · 1 shared keyword
UK · 1 shared keyword
UK · 1 shared keyword
UK · 1 shared keyword
UK · 1 shared keyword
UK
Medical Devices · UK
Medical Devices · UK
Pharmaceuticals · UK
OTC & Nutraceuticals · UK
Pharmaceuticals · UK
Medical Devices · UK